Viral Clearance Market to Hit $4.8 Billion by 2036 as 16.9% CAGR Drives Expansion
Updated
Updated · futuremarketinsights.com · Aug 10
Viral Clearance Market to Hit $4.8 Billion by 2036 as 16.9% CAGR Drives Expansion
1 articles · Updated · futuremarketinsights.com · Aug 10
Summary
$4.8 billion is the projected size of the global viral clearance market by 2036, up from $1.0 billion in 2026, adding about $3.9 billion over the forecast period.
16.9% annual growth is tied to stricter viral safety requirements in regulated biologics, where submissions and major manufacturing changes trigger recurring validation and testing work.
51.0% of 2026 method demand is expected to come from viral removal, while recombinant proteins account for 34.0% of applications and pharmaceutical and biotechnology companies for 51.0% of end-user demand.
South Korea leads the country growth outlook at 17.8% CAGR, ahead of Japan at 16.8% and the United States at 16.5%, reflecting expanding biomanufacturing capacity and demand for submission-ready studies.
Capacity and execution remain constraints because scarce process material, assay interference and the need for representative scale-down models can delay pivotal studies even as providers expand labs and testing services.